CFGS
AMRX icon

Concourse Financial Group Securities’s Amneal Pharmaceuticals AMRX Stock Holding History

Concourse Financial Group Securities’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-134
Closed -$1.37K – 2221
2019
Q1 		$1K Sell
134
-18
-12% -$238 ﹤0.01% 2119
2018
Q4 		$2K Sell
152
-26
-15% -$469 ﹤0.01% 1882
2018
Q3 		$4K Buy
+178
New +$3.75K ﹤0.01% 1431

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Concourse Financial Group Securities's AMRX Position: Q2 2019 in Review

Concourse Financial Group Securities sold out of Amneal Pharmaceuticals (AMRX) in Q2 2019, closing a stake of 134 shares — an estimated $1.37K sold.

Concourse Financial Group Securities first reported a position in AMRX in Q3 2018 and held it in 3 quarters. The position peaked at $4K in Q3 2018. 129 funds tracked by Wall St. Rank hold AMRX as of Q2 2019.

  • Concourse Financial Group Securities reported no remaining Amneal Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Concourse Financial Group Securities sold 134 Amneal Pharmaceuticals shares in Q2 2019, an estimated $1.37K.
  • Concourse Financial Group Securities first reported a position in Amneal Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Concourse Financial Group Securities's Amneal Pharmaceuticals position peaked at $4K in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2019.

Based on Concourse Financial Group Securities's 13F filing for Q2 2019, filed 13 Aug 2019.